DNA-dependent protein kinase inhibitors PI-103 and samotolisib augment CRISPR/Cas9 knock-in efficiency in human T cells

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Emina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese, Patrick Reichenbach, Stephane Grillet, Hélène Garcia, Elisabetta Cribioli, Christel Voize, Stephanie Tissot, Romain Vuillefroy de Silly, George Coukos, Kirsten Scholten, Melita Irving, Bernhard Gentner

Journal title: Cytotherapy

Journal publisher: Elsevier BV

Published year: 2025

DOI identifier: 10.1016/J.JCYT.2025.02.001

ISSN: 1465-3249